Chromosome
FDA Approves Egetis Therapeutics Emcitate as First Ever Targeted Therapy for Rare MCT8 Deficiency Care
2026-10-01
LATEST
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia





